Neurology Central

New therapeutic targets identified for Rett syndrome

A study published in the Proceedings of the National Academy of Sciences, has described the potential for reversing the genetic neurodevelopmental disorder, Rett syndrome, by targeting specific genes. Researchers from the Fred Hutchinson Cancer Research Center (WA, USA) have identified 30 genes that could be utilized to reactivate the inactive X chromosome that is silenced in the disorder.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.